Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


ZIMMER BIOMET   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2020201920182017201620152014201320122011
Period End Date12/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/201212/31/2011
Net Sales7,024.507,982.207,932.907,803.307,668.405,997.804,673.304,623.404,471.704,451.80
Total Revenues7,024.507,982.207,932.907,803.307,668.405,997.804,673.304,623.404,471.704,451.80
Cost of Products Sold2,128.302,252.602,271.902,132.902,381.801,800.601,242.801,266.701,125.201,122.00
Gross Profit--------5,286.604,197.203,430.503,356.703,346.503,329.80
Goodwill impairment645.0070.10979.70331.5031.10------96.00--
Intangible asset amortization597.60584.30595.90603.90565.90337.4092.5078.50----
Research and development372.00449.30391.70369.90365.60268.80187.40203.00225.60238.40
In-process research and development--------------------
Selling, general and administrative3,177.803,343.803,379.303,104.702,944.602,284.201,750.701,749.301,807.101,834.30
Acquisition, integration and other expense23.8012.2099.50262.20504.90----------
Restructuring and other cost reduction initiatives116.9050.0034.2017.60------------
Special items----------(839.50)(341.10)(210.30)(155.40)(75.20)
Settlement--------------------
Certain claims------------(21.50)(47.00)(15.00)(157.80)
Net curtailment and settlement--------------------
Quality remediation(50.90)(82.40)(146.90)(181.30)(53.40)----------
Operating Expenses7,112.306,844.707,899.107,004.006,847.305,530.503,636.003,554.802,299.102,305.70
Operating Income (Loss)(87.80)1,137.5033.80799.30821.10467.301,037.301,068.601,047.401,024.10
Interest expense, net212.00226.90289.30325.30355.00286.6063.1070.1072.9055.30
Interest income (expense)----------9.4011.9015.6015.6010.10
Other expense25.40(4.80)(15.60)(9.40)(66.50)(36.90)(46.70)(6.00)0.00--
Earnings before income taxes and minority interest(274.40)905.80(271.10)464.60399.60153.20939.401,008.10990.10978.90
Current Federal(96.10)65.50(46.20)438.50134.2055.80178.20207.20179.80148.40
Current State4.609.8024.402.4012.4018.9016.5020.8013.8014.30
Current Foreign(57.50)237.70116.60(13.70)101.6096.30116.00127.70108.4075.90
Deferred Federal(24.20)(90.20)37.90(1,728.50)(108.50)(120.60)(54.80)(91.80)(58.80)(2.60)
Deferred State(11.50)(4.20)(8.80)(95.50)2.30(20.00)(6.60)(8.40)0.70(0.90)
Deferred Foreign47.70(444.30)(15.70)48.00(47.00)(23.40)(29.10)(26.00)(6.70)(16.20)
Provision for Income Tax(137.00)(225.70)108.20(1,348.80)95.007.00220.20229.50237.20218.90
Minority interest--------------------
Earnings before cumulative effect of change in accounting principle--------------------
Cumulative Effect of Change in Accounting Principle--------------------
Net Earnings(137.40)1,131.50(379.30)1,813.40304.60146.20719.20778.60752.90760.00
Less : Net earnings attributable to noncontrolling interest1.50(0.10)(0.10)(0.40)(1.30)(0.80)(1.10)(1.80)(2.10)(0.80)
Net Income (loss) Available to Common Shareholders(138.90)1,131.60(379.20)1,813.80305.90147.00720.30780.40755.00760.80
Earnings before cumulative effect of change in accounting principle--------------------
Cumulative effect of change in accounting principle, net of tax--------------------
Net Earnings Per Share (Basic)(0.67)5.52(1.86)8.981.530.784.264.604.324.05
Earnings before cumulative effect of change in accounting principle--------------------
Cumulative effect of change in accounting principle, net of tax--------------------
Net Earnings Per Share (Diluted)(0.67)5.47(1.86)8.901.510.774.204.544.294.03
Weighted Average Shares Outstanding (Basic)207.00205.10203.50201.90200.00187.40169.00169.60174.90187.60
Weighted Average Shares Outstanding (Diluted)207.00206.70203.50203.70202.40189.80171.70171.80176.00188.70